Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.

Spectrum: Partisan Bill (Republican 9-0)

Status: (Introduced - Dead) 2017-04-04 - Action deferred to first calendar of 2018 [SB0922 Detail]

---

Note: Tennessee does not provide sufficient information to determine typical named revision of bills. Therefore only drafts are captured, the highest order draft will always be the current version.

Bill Drafts

Revision	Date	Format	Source	View
Draft (#1)	2017-02-09	PDF	Link	View (#1)

Amendments

Amendment	Date	Disposition	Format	Source	View
SA0075	Not Avail	Proposed	PDF	Link	View
SA0306	Not Avail	Proposed	PDF	Link	View

Supplemental Documents

Title	Description	Date	Format	Source	View
Fiscal Memo	Fiscal Memo for HA0043 (004716)	Not Avail	PDF	Link	View
Fiscal Memo	Fiscal Memo for HA0273 (006103)	Not Avail	PDF	Link	View
Fiscal Note	SB0922	Not Avail	PDF	Link	View

Social Comments on TN SB0922